Optometry in 2024: What to Expect for the New Year
WEBDec 21, 2023 · Top Achievements of 2023. Some treatments for DED have made their way through the 2023 pipeline and into pharmacies. Meibo ® (Bausch + Lomb) and Xdemvy ® (Tarsus) received FDA approval this year and the drugs have shown promise for treating evaporative DED and Demodex blepharitis, respectively, company press releases from the 2 drug manufacturers claim. 4,5
Lens-Based Myopia Control: Know When to Treat and Expect Results
WEBDec 15, 2023 · Treatments were decided based on the results of this data analysis and patients were monitored every 3 to 6 months for progression, which was defined as 0.25 D or greater myopia spherical equivalent progression (as assessed with cycloplegic autorefraction) or greater than 0.10 mm axial elongation in 6 months. Children who showed progression while on one treatment, received a change in treatment.
Red Light Therapy Provides Myopia Control ... - Optometry Advisor
WEBNov 22, 2023 · As optometrists struggle with the demand created by an emerging myopia epidemic, repeated low-level red light therapy may provide an alternative to contact lens wear or atropine treatment for slowing axial progression and spherical equivalent refraction (SER). While the treatment has yet to receive US Food and Drug Administration (FDA) approval, it has demonstrated efficacy in clinical trials ...
Optometry Advisor Redesign: New Look, Same Vision
WEBOptometry Advisor’s got a new look, but remains committed to the same high-quality clinical content and comprehensive research news updates.
Multifocals for Myopia Management – More Than Meets the Eye
WEBDec 10, 2021 · Clinicians can utilize multifocal contact lenses and fit them in accordance with a patient’s line of sight to combat myopia progression, a study shows.
FDA Alert: Optometry Drug and Device Updates
WEBJan 18, 2024 · Drug Approvals Meibo (perfluorohexyloctane ophthalmic solution) Meibo is a “semifluorinated alkane that directly targets tear evaporation by forming a monolayer at the air-liquid interface of the tear film.” 1 The drug is contained in a multiple-dose 5 mL bottle, is stored at room temperature, and is administered 4 times daily. The drop is designed to directly treat tear evaporation. 1
Technological Updates Enhance the Optometric Exam Experience
WEBMiriam Korik, OD, is a board certified optometrist who practices full scope optometry in New York, NY. She received her Doctorate of Optometry Degree from Salus University.
News Archive - Optometry Advisor
WEBSep 17, 2024 · A prospective study compared DED sign and symptom improvements following a 12-week treatment regimen of cyclosporine nanoemulsion eye drops or hyaluronic acid.
Presbyopia Drops in the Pipeline for 2023 - Optometry Advisor
WEBDec 9, 2022 · Clinicians must frequently communicate undesirable findings and results to their patients. And while presbyopia may not be a systemic disease with life-threatening repercussions, it may still be a life-altering experience for patients who are trying to process the fact that they are aging.
Progressive Lens Designs Can Affect Patient Experience
WEBJun 7, 2024 · Optometrists may see patients with presbyopia on a routine basis — 128 million of these individuals live in the US alone — but not all clinicians or their staff consider progressive lens designs when caring for these patients. 1,2 Since numerous progressive lens options exist, it may be easy for some eye care professionals to limit their lens selection to only a few of these options.
Skip to content